全文获取类型
收费全文 | 35411篇 |
免费 | 1747篇 |
国内免费 | 226篇 |
专业分类
耳鼻咽喉 | 349篇 |
儿科学 | 784篇 |
妇产科学 | 369篇 |
基础医学 | 4011篇 |
口腔科学 | 776篇 |
临床医学 | 2447篇 |
内科学 | 9706篇 |
皮肤病学 | 645篇 |
神经病学 | 2840篇 |
特种医学 | 1322篇 |
外科学 | 6184篇 |
综合类 | 124篇 |
预防医学 | 1146篇 |
眼科学 | 830篇 |
药学 | 2147篇 |
中国医学 | 65篇 |
肿瘤学 | 3639篇 |
出版年
2023年 | 261篇 |
2022年 | 544篇 |
2021年 | 1031篇 |
2020年 | 554篇 |
2019年 | 700篇 |
2018年 | 918篇 |
2017年 | 626篇 |
2016年 | 842篇 |
2015年 | 829篇 |
2014年 | 1171篇 |
2013年 | 1400篇 |
2012年 | 2156篇 |
2011年 | 2507篇 |
2010年 | 1378篇 |
2009年 | 1217篇 |
2008年 | 2055篇 |
2007年 | 2150篇 |
2006年 | 2098篇 |
2005年 | 2101篇 |
2004年 | 2089篇 |
2003年 | 1933篇 |
2002年 | 1775篇 |
2001年 | 588篇 |
2000年 | 544篇 |
1999年 | 599篇 |
1998年 | 422篇 |
1997年 | 354篇 |
1996年 | 273篇 |
1995年 | 244篇 |
1994年 | 232篇 |
1993年 | 182篇 |
1992年 | 367篇 |
1991年 | 311篇 |
1990年 | 301篇 |
1989年 | 324篇 |
1988年 | 247篇 |
1987年 | 234篇 |
1986年 | 227篇 |
1985年 | 205篇 |
1984年 | 168篇 |
1983年 | 135篇 |
1982年 | 93篇 |
1981年 | 74篇 |
1980年 | 63篇 |
1979年 | 93篇 |
1978年 | 67篇 |
1977年 | 59篇 |
1975年 | 64篇 |
1974年 | 60篇 |
1973年 | 56篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Muñoz P Giannella M Valerio M Soria T Díaz F Longo JL Bouza E 《Diagnostic microbiology and infectious disease》2007,57(4):443-446
Infliximab, a tumor necrosis factor-alpha inhibitor, is increasingly used for the therapy of different inflammatory conditions. We report the first case of cryptococcal meningitis in a patient treated with infliximab and other immunosuppressive agents, and review a further 5 reported cryptococcal infections. All of them involved fungal pneumonia. Outcome was favorable in all cases. 相似文献
993.
Kimura Yuta Tsunedomi Ryouichi Yoshimura Kiyoshi Matsukuma Satoshi Shindo Yoshitaro Matsui Hiroto Tokumitsu Yukio Yoshida Shin Iida Michihisa Suzuki Nobuaki Takeda Shigeru Ioka Tatsuya Hazama Shoichi Nagano Hiroaki 《Annals of surgical oncology》2022,29(12):7423-7433
Annals of Surgical Oncology - Poor prognosis in liver cancer is due to its high frequency of intrahepatic metastasis. Cancer stem-like cells (CSLCs), which possess the properties of stemness, tumor... 相似文献
994.
995.
996.
Anai S Goodison S Shiverick K Hirao Y Brown BD Rosser CJ 《Molecular cancer therapeutics》2007,6(1):101-111
Expression of the proto-oncogene Bcl-2 is associated with tumor progression. Bcl-2's broad expression in tumors, coupled with its role in resistance to chemotherapy and radiation therapy-induced apoptosis, makes it a rational target for anticancer therapy. Antisense Bcl-2 oligodeoxynucleotide (ODN) reagents have been shown to be effective in reducing Bcl-2 expression in a number of systems. We investigated whether treating human prostate cancer cells with antisense Bcl-2 ODN (G3139, oblimersen sodium, Genasense) before irradiation would render them more susceptible to radiation effects. Two prostate cancer cell lines expressing Bcl-2 at different levels (PC-3-Bcl-2 and PC-3-Neo) were subjected to antisense Bcl-2 ODN, reverse control (CTL), or mock treatment. Antisense Bcl-2 ODN alone produced no cytotoxic effects and was associated with G(1) cell cycle arrest. The combination of antisense Bcl-2 ODN with irradiation sensitized both cell lines to the killing effects of radiation. Both PC-3-Bcl-2 and PC-3-Neo xenografts in mice treated with the combination of antisense Bcl-2 ODN and irradiation were more than three times smaller by volume compared with xenografts in mice treated with reverse CTL alone, antisense Bcl-2 ODN alone, irradiation alone, or reverse CTL plus radiotherapy (P = 0.0001). Specifically, PC-3-Bcl-2 xenograft tumors treated with antisense Bcl-2 ODN and irradiation had increased rates of apoptosis and decreased rates of angiogenesis and proliferation. PC-3-Neo xenograft tumors had decreased proliferation only. This is the first study which shows that therapy directed at Bcl-2 affects tumor vasculature. Together, these findings warrant further study of this novel combination of Bcl-2 reduction and radiation therapy, as well as Bcl-2 reduction and angiogenic therapy. 相似文献
997.
998.
999.
Jesse D. Schold Joshua J. Augustine Anne M. Huml John OToole John R. Sedor Emilio D. Poggio 《American journal of transplantation》2020,20(3):769-778
Success of transplantation is not limited to initial receipt of a donor organ. Many kidney transplant recipients experience graft loss following initial transplantation and the benefits of expedited placement on the waiting list and retransplantation extend to this population. Factors associated with access to repeat transplantation may be unique given experience with the transplant process and prior viability as a candidate. We examined the incidence, risk factors, secular changes, and center‐level variation of preemptive relisting or transplantation (PRLT) for kidney transplant recipients in the United States with graft failure (not due to death) using Scientific Registry of Transplant Recipients data from 2007 to 2018 (n = 39 557). Overall incidence of PRLT was 15% and rates of relisting declined over time. Significantly lower PRLT was evident among patients who were African American and Hispanic, males, older, obese, publicly insured, had lower educational attainment, were diabetic, had longer dialysis time prior to initial transplant, shorter graft survival, longer distance to transplant center, and resided in distressed communities. There was significant variation in PRLT by center, median = 13%, 10th percentile = 6%, 90th percentile = 24%. Cumulatively, results indicate that despite prior access to transplantation, incidence of PRLT is modest with pronounced clinical, social, and center‐level sources of variation suggesting opportunities to improve preemptive care among patients with failing grafts. 相似文献
1000.
Lim Chetana Goumard Claire Casellas-Robert Margarida Lopez-Ben Santiago Lladó Laura Busquets Juli Salloum Chady Albiol-Quer Maria Teresa Castro-Gutiérrez Ernest Rosmorduc Olivier Feray Cyrille Ramos Emilio Figueras Joan Scatton Olivier Azoulay Daniel 《World journal of surgery》2020,44(6):1966-1974
World Journal of Surgery - The outcomes of liver resection (LR) with a narrow margin in patients with transplantable hepatocellular carcinoma (HCC) have not been studied. The aim was to assess... 相似文献